Sponsor or institution

Clinical trials and research at Vivreon Biosciences, LLC

• 6NIH research projects

NIH-funded research (6)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• VV8220 — a gut-targeted CRAC channel medicine for ulcerative colitis

  This project develops an oral, gut-restricted drug called VV8220 to reduce gut inflammation in people with ulcerative colitis.

  NIH research Vivreon Biosciences, LLC · San Diego, UNITED STATES · NIH-11159849

• A New Medicine to Prevent Opioid Dependence

  This project aims to create a new non-opioid medicine to help prevent people from becoming dependent on opioids after receiving them in the hospital.

  NIH research Vivreon Biosciences, LLC · San Diego, UNITED STATES · NIH-11135560

• Creating a new treatment to prevent opioid dependence

  This study is testing a new non-opioid medication to help prevent patients from becoming dependent on opioids after their hospital stay, especially for those who have used opioids for a while during their treatment.

  NIH research Vivreon Biosciences, LLC · San Diego, UNITED STATES · NIH-11072769

• Developing a new treatment for ulcerative colitis that targets the gut

  This study is working on a new medicine to help people with ulcerative colitis by specifically targeting the inflammation in their gut, aiming to provide better relief for those who haven't found success with current treatments.

  NIH research Vivreon Biosciences, LLC · San Diego, UNITED STATES · NIH-11007576

• New treatment to slow muscle weakening in Duchenne muscular dystrophy

  This study is testing a new treatment that aims to help people with Duchenne muscular dystrophy (DMD) by improving how their muscle cells handle calcium, which could slow down muscle weakness and damage.

  NIH research Vivreon Biosciences, LLC · San Diego, UNITED STATES · NIH-10921411

• Improving cancer treatment outcomes by blocking side effects of immunotherapy

  This study is testing a new pill called VV2003 to help cancer patients who experience stomach issues from their immunotherapy treatments, so they can keep fighting cancer without needing other medications that might make their treatment less effective.

  NIH research Vivreon Biosciences, LLC · San Diego, UNITED STATES · NIH-10631213

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →